The UK Government is considering using weight-loss drugs to help support obese people in returning to work and reduce the high rates of long-term sickness, which have become a significant strain on the economy.
Health Minister Wes Streeting suggested that the drug — a rival to Novo Nordisk's Ozempic which has the same effects but produced by pharmaceutical rival Eli Lilly — could potentially improve the nation’s health.
Continue reading for FREE!
Sign up for a myGrapevine account to get:
- Unlimited access to News content
- The latest Features, Columns & Opinions
- A full range of specialist HR newsletters to choose from